Showing 1761-1770 of 9830 results for "".
Clinical Decision Support and Point-of-Care Information for Dermatology
https://practicaldermatology.com/topics/practice-management/clinical-decision-support-and-point-of-care-information-for-dermatology/21652/Clinicians need to be aware of the full capabilities and benefits of available tools and how they can be used most efficiently.Clinical Case Report: Severe Allergic Contact Dermatitis of Eyelids: When Topical and Oral Steroids Are Not an Option
https://practicaldermatology.com/topics/general-topics/clinical-case-report-severe-allergic-contact-dermatitis-of-eyelids-when-topical-and-oral-steroids-are-not-an-option/21878/Topical calcineurin inhibitors may present a therapeutic option for contact dermatitis of the eyelids.Efficacy and Safety of Newly Approved Oral Sarecycline for Acne
https://practicaldermatology.com/columns/clinical-focus-1/efficacy-and-safety-of-newly-approved-oral-sarecycline-for-acne/22996/A closer look at the first NCE approved to treat acne in more than a decade.Shedding Some Light on Hair Loss
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/shedding-some-light-on-hair-loss/23191/A look at the evolution of laser- and LED-assisted hair regrowth and the future of light therapy in the treatment of androgenetic alopeciaEducation and the Young and Not-So-Young Dermatologist
https://practicaldermatology.com/columns/editors-message/education-and-the-young-and-not-so-young-dermatologist/23904/The ABCDEs of AI for Skin Cancer Detection
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-abcdes-of-ai-for-skin-cancer-detection/23695/Key considerations for dermatologists as AI continues to expand.Behind the Sunscreen Recall
https://practicaldermatology.com/topics/skin-cancer-photoprotection/behind-the-sunscreen-recall/23557/Use the latest media buzz as an excuse to educate.Currents: Spotlight on Biologics
https://practicaldermatology.com/topics/psoriasis/currents-spotlight-on-biologics/23548/Cutaneous T-Cell Lymphoma: Mogamulizumab as a Novel Treatment for Refractory Mycosis Fungoides and Sezary Syndrome
https://practicaldermatology.com/youngmd-connect/resident-resource-center/Cutaneous-T-Cell-Lymphoma-Mogamulizumab-as-a-Novel-Treatment-for-Refractory-Mycosis-Fungoides-and-Sezary-Syndrome/23409/An overview of the diagnosis and prognosis of CTCL.Key Lessons for Surviving COVID-19 as a Dermatologist
https://practicaldermatology.com/topics/practice-management/key-lessons-for-surviving-covid-19-as-a-dermatologist/23405/Here are 10 lessons we learned about crisis preparedness from leading dermatologists.